"Lactate Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alcohol oxidoreductases with substrate specificity for LACTIC ACID.
Descriptor ID |
D045022
|
MeSH Number(s) |
D08.811.682.047.551
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lactate Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Lactate Dehydrogenases".
This graph shows the total number of publications written about "Lactate Dehydrogenases" by people in this website by year, and whether "Lactate Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Lactate Dehydrogenases" by people in Profiles.
-
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome. Scand J Rheumatol. 2020 09; 49(5):414-416.
-
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020 08 14; 12(15):15670-15681.
-
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. Thromb Res. 2020 09; 193:170-172.
-
Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020 06; 95(6):E131-E134.
-
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies. J Nephrol. 2018 06; 31(3):405-410.
-
Usefulness of serum lactate dehydrogenase/pleural fluid adenosine deaminase ratio for differentiating Mycoplasma pneumoniae parapneumonic effusion and tuberculous pleural effusion. J Infect. 2017 12; 75(6):581-583.